Depression linked to E-cigarettes and cigarette use among college students

Jul.15.2022
Depression linked to E-cigarettes and cigarette use among college students
Depression linked to tobacco use among college students, according to study in Psychiatry Research Communications.

A study published in the Journal of Psychiatric Research found a positive correlation between depression and tobacco product use, including electronic and traditional cigarettes, among college students.


This study analyzed data from the Fall 2020 cohort of the Healthy Minds Study, which collected information on the psychological health of undergraduate and graduate students, as well as sociodemographic covariates and other relevant factors. The online survey was distributed to 36 universities across the United States between September and December 2020. Five of these universities included drug use in the survey, resulting in a sample size of 2,115 for this study.


Attendees reported on individuals who exclusively use e-cigarettes, exclusively use traditional cigarettes, and those who use a combination of both. The symptoms of depression were measured using the Patient Health Questionnaire-9 (PHQ-9) for the participants. The PHQ-9 questionnaire scores the answers on a scale ranging from 0 to 27, with scores above 5 indicating possible depression.


The study measures societal norms surrounding tobacco use and perceptions of risks associated with tobacco use. In order to gauge societal norms, participants were asked to estimate the percentage of college students who smoke. Responses to questions about tobacco risks were measured on a scale of 1 to 4, with 1 indicating "no risk" and 4 indicating "high risk.


Using logistic regression analysis, this study examines the social norms of tobacco use among individuals with symptoms of depression, perceived risk of smoking, and those who use both traditional cigarettes and e-cigarettes.


The average age of participants was 23.41±7.84 years, with 43.8% being female and 85.6% being white. Participants reported that in the past 30 days, 22.38% only used e-cigarettes, 7.89% only used traditional cigarettes, and 2.72% used a combination of both.


A study has found that 33.1% of participants met the criteria for possible depression, with an average score of 8.00 ± 6.33. The levels of depression were higher among all groups who used tobacco products: those who only used e-cigarettes (OR, 1.08; 95%CI, 1.06-1.10), those who only smoked traditional cigarettes (OR, 1.09; 95%CI, 1.06-1.12), and those who used both (OR, 1.05; 95%CI, 1.00-1.10).


Participants reported medium risks associated with smoking and vaping, with average scores of 3.26 ± 1.01 and 2.85 ± 0.98, respectively. The perceived social norms related to the use of electronic cigarettes (OR, 1.01; 95% CI 1.00-1.02) and cigarettes (OR, 1.02; 95% CI, 1.00-1.03) were higher and associated with increased use of these tobacco products.


Most participants in the study were white students, so the results may not be representative. Although the researchers emphasized the confidentiality of the responses, students may have underreported their tobacco use.


Overall, researchers have concluded that there is a link between depression and both e-cigarettes and traditional cigarettes. They have found that the likelihood of using e-cigarettes and traditional cigarettes is positively associated with the likelihood of depression.


The researchers stated that gaining further knowledge on psychosocial and mental health related factors could provide valuable information in understanding the smoking habits and associated risks in college students. This understanding can guide the development of smoking cessation policies.


I'm sorry, but without any text to translate, I cannot provide a response.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain Cigarette Volumes Fall 5.2% in August, BAT Drops 14.5%, JTI Gains Share; France Down 8.3% on Adjusted Basis
Spain's cigarette volumes declined 5.2% year over year in August 2026, according to government data cited by UBS and reported by Investing.com on October 7. British American Tobacco's volumes fell 14.5%, followed by Imperial Brands at 8.8%, Philip Morris International at 6.6% and Japan Tobacco at 4.6%. JTI was the only one of the four companies to gain cigarette market share, rising six basis points to 26.7%. In France, official customs data showed an unadjusted 3.7% decline in cigarette deliveries. Adjusting for the difference in delivery days produces a decline of approximately 8.3%, consistent with the UBS figure. The bank also estimated the earnings exposure of major tobacco companies to both markets.
Market
Oct.13
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
JAMA Study: U.S. Vape Directories Fail to Sustainably Curb Unlisted Sales as Product Shifts May Redistribute Brand Share 2Firsts Recommended
A study by CDC Foundation researchers found no sustained decline in e-cigarette sales across Alabama, Oklahoma and Louisiana, the first three U.S. states to implement e-cigarette directory laws. Louisiana initially saw a significant sales decline, followed by a rebound and a persistent reduction in product availability. Sales also shifted from nontobacco-flavored disposables toward prefilled cartridges, with Vuse Alto driving much of the increase in menthol cartridges. By April 2025, unlisted products still accounted for more than half of e-cigarette nicotine sales in all three states.
Sep.18
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania Vape Directory Enforcement Starts Oct. 19, Barring Retail Sales of Unlisted Products
Pennsylvania's Act 57 vape directory regime will reach the end of its 120-day inventory transition period on Oct. 19. Nicotine-containing e-cigarettes intended for retail sale in the state that are not listed on the Attorney General's ENDS directory will then be barred from retail sale and treated as contraband subject to seizure, forfeiture and destruction. Manufacturers face annual product certification, brand- and style-based fees and a minimum $50,000 surety bond, while retailers and wholesalers must source through licensed channels and monitor the directory.
Regulations
Oct.08
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26